导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.86% | 298/1050 |
| 近一周 | -2.28% | 521/1104 |
| 近一月 | -0.55% | 115/1102 |
| 近一季 | -6.09% | 467/1092 |
| 近半年 | 5.78% | 306/1070 |
| 近一年 | 23.76% | 197/1018 |
| 近两年 | 110.34% | 161/926 |
| 近三年 | 89.46% | 107/834 |
| 成立以来 | 315.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.43% 586/1070 |
20.76% 375/1101 |
- - |
- - |
| 2025 | 52.64% 167/1065 |
-0.84% 848/1014 |
5.74% 259/1038 |
34.54% 281/1050 |
8.20% 69/1065 |
| 2024 | 18.19% 114/1011 |
2.08% 208/960 |
-0.75% 359/983 |
14.35% 269/991 |
2.03% 234/1011 |
| 2023 | -16.54% 581/952 |
-2.03% 716/880 |
0.81% 144/895 |
-11.03% 624/915 |
-5.02% 503/952 |
| 2022 | -19.96% 321/867 |
-15.05% 266/773 |
8.66% 319/806 |
-9.05% 195/845 |
-4.67% 635/867 |
| 2021 | 25.75% 108/740 |
-1.97% 223/580 |
22.98% 116/659 |
4.25% 137/704 |
0.06% 436/740 |
| 2020 | 66.16% 158/554 |
-2.52% 223/419 |
31.61% 104/466 |
11.00% 228/517 |
16.68% 174/554 |
| 2019 | 57.60% 92/410 |
24.53% 737/1146 |
6.94% 25/1228 |
10.81% 100/390 |
6.80% 284/410 |
| 2018 | -24.34% 135/349 |
- - |
-2.30% 125/990 |
-4.55% 435/1000 |
-14.22% 835/1080 |
| 2017 | 27.49% 53/285 |
- - |
- - |
- - |
- - |
| 2016 | 4.40% 19/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中银战略新兴产业股票A VS. 东吴新产业精选股票A(580008) |